The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

MALVERN, Pa.--(BUSINESS WIRE)--LifeScan Inc. (“LifeScan” or the “Company”), a world leader in blood glucose monitoring, today announced that its Chapter 11 Plan of Reorganization (the “Plan”) has been ...

MALVERN, Pa., Sept. 29, 2020 /PRNewswire/ -- LifeScan, a world leader in blood glucose monitoring and maker of the iconic OneTouch® brand, today announced the launch of its OneTouch Amazon storefront ...

Diabetes Experts Affirm Importance of Self-Monitoring of Blood Glucose (SMBG) and Expanded Potential for Healthcare Professionals and their Patients Living with Diabetes The OneTouch Verio Reflect™ ...

Press Release MILPITAS, CA - LifeScan, Inc. is conducting a voluntary recall in the United States of eight lots of OneTouch® SureStep® Test Strips, used by people with diabetes to measure their blood ...

Former Roche, Glutalor executive will help usher in a new era of innovation, growth, and expansion for the newly independent blood glucose monitoring company CHESTERBROOK, Pa., April 8, 2019 ...

The partnership announced in March between Johnson & Johnson subsidiary LifeScan and diabetes management company WellDoc has entered a new stage with a commercial partnership agreement, the companies ...

MINNEAPOLIS--(BUSINESS WIRE)--Medtronic, Inc. (NYSE:MDT) today announced an exclusive United States agreement with LifeScan, Inc., a Johnson & Johnson (NYSE:JNJ) company, to distribute and co-market ...

(Reuters) - Johnson & Johnson said on Friday it was offered about $2.1 billion for its LifeScan Inc unit, which makes blood glucose monitoring products, by private equity firm Platinum Equity, another ...

(Reuters) - Johnson & Johnson (JNJ.N) said on Friday it was offered about $2.1 billion for its LifeScan Inc unit, which makes blood glucose monitoring products, by private equity firm Platinum Equity, ...